Fear of Falling: An Independent Factor Affecting Health-Related Quality of Life in Patients with Parkinson's Disease

Albay, Vasfiye Burcu; Tutuncu, Mesude

doi:10.4103/0028-3886.319225

Cited by 4 publications

(3 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, a 2021 report detailed occipital neuralgia secondary to MS. Two cases were identified wherein the solitary (and, in one case, the initial) manifestation of acute MS symptomatology was an occipital neuralgia phenotype referable to demyelinating lesions in the upper cervical spinal cord. In both cases, treatment with IV methylprednisolone led to improvement 38 …”

Section: Occipital Neuralgiamentioning

confidence: 86%

Cranial Neuralgias

Nahas

2024

CONTINUUM: Lifelong Learning in Neurology

View full text Add to dashboard Cite

Objective The cranial neuralgias are relatively rare, but recognizing these syndromes and distinguishing among them is critical to reducing unnecessary pain and disability for affected patients. Despite their distinctive features, cranial neuralgias may go undiagnosed or misdiagnosed for several years. A notable proportion of cranial neuralgia presentations are due to secondary causes and require targeted treatment. The purpose of this article is to review the diagnosis and management of cranial neuralgias encountered in clinical practice. Latest Developments In 2020, the International Classification of Orofacial Pain was released for the first time. Modeled after the International Classification of Headache Disorders, it includes updated terminology for cranial neuralgias. The underlying pathophysiology of the cranial neuralgias is currently believed to be rooted in both peripheral and central nociceptive systems. In addition, a growing number of familial cases are being identified. Recent therapeutic advancements include a better understanding of how to utilize older therapies and procedures more effectively as well as the development of newer approaches. Essential Points Cranial neuralgia syndromes are rare but important to recognize due to their debilitating nature and greater likelihood of having potentially treatable underlying causes. While management options have remained somewhat limited, scientific inquiry is continually advancing the understanding of these syndromes and how best to address them.

show abstract

Section: Occipital Neuralgiamentioning

confidence: 86%

Cranial Neuralgias

Nahas

2024

CONTINUUM: Lifelong Learning in Neurology

View full text Add to dashboard Cite

show abstract

“…Consequently, they can experience fearful anticipation of falls, developing a fear of falling (FOF) ( 8 , 9 ). The FOF can ultimately reduce balance performance and limit the person’s activity levels ( 8 , 10 ), compromising one’s quality of life ( 11 ). Fall prevention programs mainly targeted intrinsic (e.g., muscle weakness, balance problem) or extrinsic (e.g., environmental hazards) fall risk factors ( 9 , 12 ).…”

Section: Introductionmentioning

confidence: 99%

Landing wise program: feasibility study protocol for Parkinson’s disease

Fernandes,

Domingos,

Família

et al. 2023

Front. Med.

View full text Add to dashboard Cite

Regardless of the benefits of fall prevention programs, people with Parkinson’s disease (PD) will still fall. Therefore, it is crucial to explore novel therapeutic approaches that are well-accepted and effective for addressing fall risk and the fear of falls among this population. The present study aims to assess the feasibility of the Landing Wise program as a therapeutic intervention for reducing the fear of falling in people with PD. A mixed-methods study will be conducted using convenience sampling to recruit 20 people with PD with a moderate concern of falling from a Parkinson’s Patients Association. In addition to usual care, participants will attend 2 days per week, 90 min group sessions for 8 weeks. The intervention combines group cognitive behavioral intervention with the training of safe landing strategies. Feasibility will be assessed by six key domains (recruitment strategy and rates, enrollment, retention, acceptability, reasons for decline/withdrawal, and adverse events). Quantitative data will be analyzed using descriptive statistics to characterize the sample, followed by inferential statistics to evaluate differences in the Short Falls Efficacy Scale-International Scale, Movement Disorder Society Unified Parkinson’s Disease Rating Scale, Timed Up Go, 6-Minutes Walking Distance, and fall frequency and severity scores between baseline and final assessment. Qualitative data will be analyzed using an inductive thematic analysis process. There is a growing interest in developing new effective therapeutic approaches for people with PD. If proven program feasibility, this study precedes a randomized controlled trial to establish the effectiveness of the Landing Wise program.

show abstract

“…Meanwhile, higher global cognitive performance (measured with the Mini Mental State Examination) was found to be determinant for maintenance of positive long-term effects of home-based physical training in individuals with advanced PD ( Nieuwboer et al, 2002 ). Also, depression and FOF are associated with increased walking variability as well as decreased walking speed and quality of life in individuals with PD ( Rochester et al, 2008 ; Brozova et al, 2009 ; Jacob et al, 2010 ; Rahman et al, 2011 ; Allen et al, 2013 ; Lord et al, 2013 ; Lindholm et al, 2014 ; Albay and Tutuncu, 2021 ; Atrsaei et al, 2021 ; Dragašević-Mišković et al, 2021 ). FOF is also considered a determinant of increased risk of falling ( Allen et al, 2013 ) alongside with avoidance of physical activity in situations with increased fall-related activity ( Kader et al, 2016 ).…”

Section: Introductionmentioning

confidence: 99%

Cognitive parameters can predict change of walking performance in advanced Parkinson’s disease – Chances and limits of early rehabilitation

Geritz

Welzel²,

Hansen³

et al. 2022

Front. Aging Neurosci.

View full text Add to dashboard Cite

IntroductionLinks between cognition and walking performance in patients with Parkinson’s disease (PD), which both decline with disease progression, are well known. There is lack of knowledge regarding the predictive value of cognition for changes in walking performance after individualized therapy. The aim of this study is to identify relevant predictive cognitive and affective parameters, measurable in daily clinical routines, for change in quantitative walking performance after early geriatric rehabilitation.MethodsForty-seven acutely hospitalized patients with advanced PD were assessed at baseline (T1) and at the end (T2) of a 2-week early rehabilitative geriatric complex treatment (ERGCT). Global cognitive performance (Montreal Cognitive Assessment, MoCA), EF and divided attention (Trail Making Test B minus A, delta TMT), depressive symptoms, and fear of falling were assessed at T1. Change in walking performance was determined by the difference in quantitative walking parameters extracted from a sensor-based movement analysis over 20 m straight walking in single (ST, fast and normal pace) and dual task (DT, with secondary cognitive, respectively, motor task) conditions between T1 and T2. Bayesian regression (using Bayes Factor BF10) and multiple linear regression models were used to determine the association of non-motor characteristics for change in walking performance.ResultsUnder ST, there was moderate evidence (BF10 = 7.8, respectively, BF10 = 4.4) that lower performance in the ∆TMT at baseline is associated with lower reduction of step time asymmetry after treatment (R2adj = 0.26, p ≤ 0.008, respectively, R2adj = 0.18, p ≤ 0.009). Under DT walking-cognitive, there was strong evidence (BF10 = 29.9, respectively, BF10 = 27.9) that lower performance in the ∆TMT is associated with more reduced stride time and double limb support (R2adj = 0.62, p ≤ 0.002, respectively, R2adj = 0.51, p ≤ 0.009). There was moderate evidence (BF10 = 5.1) that a higher MoCA total score was associated with increased gait speed after treatment (R2adj = 0.30, p ≤ 0.02).DiscussionOur results indicate that the effect of ERGT on change in walking performance is limited for patients with deficits in EF and divided attention. However, these patients also seem to walk more cautiously after treatment in walking situations with additional cognitive demand. Therefore, future development of individualized treatment algorithms is required, which address individual needs of these vulnerable patients.

show abstract

Fear of Falling: An Independent Factor Affecting Health-Related Quality of Life in Patients with Parkinson's Disease

Cited by 4 publications

References 17 publications

Cranial Neuralgias

Cranial Neuralgias

Landing wise program: feasibility study protocol for Parkinson’s disease

Cognitive parameters can predict change of walking performance in advanced Parkinson’s disease – Chances and limits of early rehabilitation

Contact Info

Product

Resources

About